ATE549345T1 - Verfahren zur herstellung von medrogeston - Google Patents

Verfahren zur herstellung von medrogeston

Info

Publication number
ATE549345T1
ATE549345T1 AT06700710T AT06700710T ATE549345T1 AT E549345 T1 ATE549345 T1 AT E549345T1 AT 06700710 T AT06700710 T AT 06700710T AT 06700710 T AT06700710 T AT 06700710T AT E549345 T1 ATE549345 T1 AT E549345T1
Authority
AT
Austria
Prior art keywords
medrogeston
producing
methylenepregn
medrogestone
heterogeneously
Prior art date
Application number
AT06700710T
Other languages
English (en)
Inventor
Jean-Luc Moutou
Benoit Rondot
Jean Lafay
Philippe Maillos
Original Assignee
Abbott Products Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Products Gmbh filed Critical Abbott Products Gmbh
Application granted granted Critical
Publication of ATE549345T1 publication Critical patent/ATE549345T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT06700710T 2005-01-18 2006-01-17 Verfahren zur herstellung von medrogeston ATE549345T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64405305P 2005-01-18 2005-01-18
EP05100267 2005-01-18
PCT/EP2006/050242 WO2006077209A1 (en) 2005-01-18 2006-01-17 Method for preparing medrogestone

Publications (1)

Publication Number Publication Date
ATE549345T1 true ATE549345T1 (de) 2012-03-15

Family

ID=34938526

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06700710T ATE549345T1 (de) 2005-01-18 2006-01-17 Verfahren zur herstellung von medrogeston

Country Status (5)

Country Link
EP (1) EP1841778B1 (de)
JP (1) JP2008527022A (de)
AT (1) ATE549345T1 (de)
CA (1) CA2595317A1 (de)
WO (1) WO2006077209A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013029673B1 (pt) 2011-05-20 2021-11-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonistas de receptor de cb1
EP3176176A1 (de) 2012-11-28 2017-06-07 INSERM (Institut National de la Santé et de la Recherche Médicale) 3-(4'-substituierte)-benzyl-äther von pregnenolonederivate
HU231125B1 (hu) 2016-12-16 2020-12-28 Richter Gedeon Nyrt. Ipari eljárás Nomegesztrol-acetát előállítására

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3170936A (en) * 1963-08-07 1965-02-23 American Home Prod Process for the preparation of 6, 17alpha-dimethyl-4, 6-pregnadiene-3, 20-dione
US3479342A (en) * 1965-03-25 1969-11-18 Smithkline Corp 6,6-ethylene pregnenes
DE3204281C1 (de) * 1982-02-05 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 6-Methyl-delta?-3-ketosteroiden
US5428151A (en) * 1994-05-05 1995-06-27 American Home Products Corporation Medrogestrone production

Also Published As

Publication number Publication date
EP1841778B1 (de) 2012-03-14
CA2595317A1 (en) 2006-07-27
WO2006077209A1 (en) 2006-07-27
EP1841778A1 (de) 2007-10-10
JP2008527022A (ja) 2008-07-24

Similar Documents

Publication Publication Date Title
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
DE602005015174D1 (de) Verfahren zur herstellung von montelukast-natrium
DE502006005581D1 (de) Ukmischungen, ein verfahren zu deren herstellung, verfahren zur herstellung von verbund-formteilen und deren verwendung
ATE540009T1 (de) Verfahren zur herstellung von ethylen
DE112005003709A5 (de) Mischung zur Herstellung von selbstverdichtendem Beton
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
DE502006001281D1 (de) Verfahren zur herstellung substituierter biphenyle
ATE544566T1 (de) Verfahren zur herstellung von dünne metallnanodrähte durch biotemplating
ATE461934T1 (de) Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-car onsäure -lacton und schlüsselzwischenprodukte für dieses verfahren
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
DE602007001567D1 (de) Verfahren zur Herstellung von Fotomasken-Rohlingen
WO2008148473A3 (de) Verfahren zur herstellung von 17 alpha-acetoxy-6-methylenpregn-4-en-3, 20-dion, medroxyprogesteronacetat und megestrolacetat
ATE468349T1 (de) GROßTECHNISCHES VERFAHREN ZUR HERSTELLUNG VON 17- HYDROXY-6BETA, 7BETA, 15BETA,16BETA-BISMETHYLEN-3-OXO-17ALPHA-PREGN-4 EN-21-CARBONSÄURE-GAMMA- LACTON UND SCHLÜSSELZWISCHENPRODUKTE FÜR DIESES VERFAHREN
ATE549345T1 (de) Verfahren zur herstellung von medrogeston
ATE518828T1 (de) Ein-topf-verfahren zur herstellung von 3-(2,2,2- trimethylhydrazinium)propionat-dihydrat
ATE501104T1 (de) Verfahren zur herstellung von 1,2,2,2-tetrafluor- ethyl-difluor-methylether
ATE391115T1 (de) Verfahren zur herstellung von diketenacetalen
ATE464289T1 (de) Neues verfahren zur herstellung von thoc
ATE553080T1 (de) Verkürztes verfahren zur herstellung von l- lobelin
ATE352549T1 (de) Verfahren zur herstellung von desloratadin
DE602006011824D1 (de) Verfahren zur Herstellung von Schlämmen
ATE554064T1 (de) Verfahren zur herstellung von entacapon
ATE502045T1 (de) Verfahren zur herstellung von perindoprilerbumin